Jonathan Lim

Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance

Jonathan Lim, Alberto Delaidelli, Sean W. Minaker et al. · Proceedings of the National Academy of Sciences · 2019 · 306 citations · Full text

Medicine, Molecular Biology, Oncology +17

Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation

Fabienne Müller, Jonathan Lim, Christina M. Bebber et al. · Cell Death and Differentiation · 2022 · 128 citations · Full text

Medicine, Molecular Biology, Oncology +17

Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma

Haifeng Zhang, Christopher S. Hughes, Wei Li et al. · Cancer Discovery · 2021 · 109 citations · Full text

Medicine, Cancer Biology, Oncology +16

The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

Ulvi Ahmadov, Daniel Picard, Jasmin Bartl et al. · Cell Death and Disease · 2021 · 54 citations · Full text

Life Sciences, Genetics, Oncology +17

mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism

Tal Levy, Kai Voeltzke, Laura A. Hruby et al. · Nature Communications · 2024 · 48 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17